Showing results (61-70 of 151) with videos related to

Sort By:
Pageof 16
Diabetes, Obesity & Metabolism|February 1, 2020
Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add-on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel-design, open-label, Phase 3 trialTina Vilsbøll, Ella Ekholm, Eva Johnsson, et al.
Diabetologia|May 10, 2014
Changes in HbA1c and frequency of measuring HbA1c and adjusting glucose-lowering medications in the 10 years following diagnosis of type 2 diabetes: a population-based study in the UKMarcus Lind, Aldina Pivodic, Lucia Cea-Soriano, et al.
Acta Anaesthesiologica Scandinavica|October 15, 2024
Insulin requirement trajectories during COVID-19 versus non-COVID-19 critical illness-A retrospective cohort studyNavid Soltani, Henrike Häbel, Anca Balintescu, et al.
Diabetes & Vascular Disease Research|June 21, 2023
Glycemic control and outcome after carotid intervention in patients with T2D: A Swedish nationwide cohort studyAlexander Zabala, Anders Gottsäter, Marcus Lind, et al.
Diabetologia|September 8, 2021
Risk factors and incidence over time for lower extremity amputations in people with type 1 diabetes: an observational cohort study of 46,088 patients from the Swedish National Diabetes RegistrySara Hallström, Ann-Marie Svensson, Aldina Pivodic, et al.
Clinical Endocrinology|May 12, 2017
Prevalence of primary aldosteronism among patients with type 2 diabetesMauro Tancredi, Gudmundur Johannsson, Björn Eliasson, et al.
Journal of Diabetes Science and Technology|July 24, 2025
Accuracy of Glucose Trends by Subcutaneous Continuous Monitoring vs Intermittent Arterial Measurements in Critically Ill PatientsOla Friman, Marcus Lind, Ragnar Thobaben, et al.
The Journal of Clinical Endocrinology and Metabolism|February 27, 2024
Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin GlargineDonald C Simonson, Marcia A Testa, Ella Ekholm, et al.
Diabetes Technology & Therapeutics|March 7, 2017
A Clinical Trial of the Accuracy and Treatment Experience of the Flash Glucose Monitor FreeStyle Libre in Adults with Type 1 DiabetesArndís F Ólafsdóttir, Stig Attvall, Ulrika Sandgren, et al.
The Lancet. Diabetes & Endocrinology|August 26, 2017
Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control studySofia Dahlqvist, Annika Rosengren, Soffia Gudbjörnsdottir, et al.
Pageof 16